345 Park Avenue
New York
NY
10154-0037
USA
212-546-4000
At Bristol-Myers Squibb, our mission is to extend and enhance human life by Providing the hightest-quality pharmaceuticals and health care products.
Product Categories
Related Content
March 27, 2024 — Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug ...
March 27, 2024
November 6, 2023 — Bristol Myers Squibb announced that research across the company’s cardiovascular franchise will be ...
November 06, 2023
April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...
April 29, 2022
April 12, 2022 – A majority of patients with obstructive hypertrophic cardiomyopathy (HCM)—a condition that results in ...
April 12, 2022
July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin ...
July 29, 2021
May 15, 2021 — A new analysis of the Phase 3 EXPLORER-HCM study evaluating mavacamten, an investigational, first-in ...
May 15, 2021November 16, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes associated ...
November 16, 2017November 9, 2012 — Bristol-Myers Squibb Co. and Pfizer Inc. announced that the reductions in stroke or systemic embolism ...
November 09, 2012
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA ...
October 01, 2012November 16, 2011 — Non-adherence to antiplatelet therapy – which prevents blood clots following percutaneous coronary ...
November 16, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now